Skip to main content
TipRanks
Go Ultimate75% OFF

Aridis Pharmaceuticals (ARDS) Income Statement

203 Followers

Aridis Pharmaceuticals Income Statement

Last quarter (Q3 2023), Aridis Pharmaceuticals's total revenue was $417.00K. In Q3, Aridis Pharmaceuticals's net income was $-83.00K. See Aridis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 22Mar 22Dec 20Mar 20Dec 18
$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
$ 29.99M$ 43.71M$ 23.40M$ 30.11M$ 26.87M
Depreciation and Amortization$ 487.00K$ 435.00K$ 337.00K$ 338.00K$ 283.00K
$ -29.51M$ -43.00M$ -22.06M$ -28.75M$ -23.83M
$ -29.99M$ -43.71M$ -22.40M$ -29.09M$ -24.12M
$ -378.00K$ 518.00K$ 68.00K$ -594.00K$ 2.01M
$ -30.37M$ -43.19M$ -22.33M$ -29.68M$ -22.11M
$ -30.75M$ -42.28M$ -22.33M$ -29.68M$ -22.11M
Per Share Metrics
Basic EPS$ -1.64$ -3.44$ -2.44$ -3.43$ -7.02
Diluted EPS$ -1.64$ -3.44$ -2.44$ -3.43$ -7.02
Weighted Average Shares Outstanding18.78M12.29M9.17M8.46M3.15M
Weighted Average Shares Outstanding (Diluted)18.78M12.29M9.17M8.46M3.15M

Currency in USD

Aridis Pharmaceuticals Earnings and Revenue History

-50M-25M025M-3600 %-2400 %-1200 %0 %EarningsProfit Margin201720182019202020212022RevenueEarningsProfit Margin